Worcester, MA, United States of America

Bryan A Fiamengo

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 15.9

ph-index = 2

Forward Citations = 103(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bryan A. Fiamengo

Introduction

Bryan A. Fiamengo is an accomplished inventor based in Worcester, MA, with an impressive portfolio of patents focused on advanced pharmaceutical compounds. His work aims to address significant health challenges, particularly in the fields of immunology and oncology. With two patents to his name, Fiamengo has made notable strides in the development of compounds that could play crucial roles in medical treatment.

Latest Patents

Fiamengo's latest patents revolve around tricyclic compounds, which are defined as a compound of Formula (I) along with pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, and various stereoisomers and isomers. These compounds are particularly beneficial for treating immunological and oncological conditions, showcasing their potential impact on critical areas of healthcare.

Career Highlights

Currently working at AbbVie Inc., Fiamengo has utilized his expertise to further the development of innovative therapeutic solutions. AbbVie is recognized for its commitment to creating advanced medications and therapies, making it an ideal environment for innovators like Fiamengo.

Collaborations

In his pursuit of innovation, Fiamengo collaborates with esteemed colleagues such as Neil Wishart and Maria A. Argiriadi. Teamwork plays a vital role in the advancement of their collective goals, facilitating knowledge sharing and fostering creativity within their research.

Conclusion

Bryan A. Fiamengo exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of tricyclic compounds, are paving the way for new treatments in immunology and oncology. As he continues to collaborate with talented professionals at AbbVie Inc., the future holds great promise for further advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…